Professor Risteárd Ó Laoide:

No. We are in the planning process for it. We have not had funding for surgical centralisation. I came into this job at the end of July. We have begun to look at the surgical disciplines and at prioritising the centralisation programme. That is the process we are in at the moment. Rectal cancer is a key one because it has a significant benefit for patients' survival. Gynae-oncology is another one, particularly in the area of ovarian cancer. That also has significant benefits and we are currently in the process of planning that.